Trial Profile
Effect of anagliptin on lipid metabolism in non-diabetic men
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 21 Mar 2015
Price :
$35
*
At a glance
- Drugs Anagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 19 Mar 2015 Status changed from recruiting to discontinued, according to University Hospital Medical Information Network - Japan record.
- 13 Aug 2013 New trial record